Home » Advocacy » Letters, Testimony & Comments

Letters, Testimony & Comments

Comments on Bioavailability and Bioequivalence Standards
May 11, 2004
May 11, 2004 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20857 Re: Docket No. 2004N-0087, Federal Register March 3, 2004 (Volume 69, Number 42, Page 9982) "...
New York Biotech Association
May 10, 2004
Memo in opposition of NY Senate Bill 6537, which would prohibit the sale of transgenic aquatic species (May 10, 2004).
BIO Comments on Disease Awareness
May 10, 2004
May 10, 2004 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, Maryland 20857 Re: Docket No. 2004D-0042, Federal Register February 10, 2004 (Volume 69, Number 27), Pages 6308-6309...
BIO Letter to Louisiana Governor Kathleen Blanco
May 7, 2004
Opposing House Bill 803, which would prohibit all forms of human cloning in the state (May 7, 2004).
Response to FTC Patent System Reform Recommendations
April 26, 2004
Statement Before the NIH Blue Ribbon Panel on Conflict of Interest Policies
April 16, 2004
BIO Testimony to the HHS Importation Task Force
April 14, 2004
April 14, 2004, 9:00 a.m. -5:00 p.m. Natcher Auditorium, Building 45, National Institutes of Health (NIH) 9000 Rockville Pike, Bethesda, MD 20892 The Biotechnology Industry Organization (BIO) appreciates the opportunity to present its views...
BIO Statement on HCR 270/HR 180
April 7, 2004
Please accept this statement on  behalf of the Biotechnology Industry Organization (BIO) and its member companies regarding HCR270/HR180, which urges the state to establish advisory boards regarding "genetically modified organisms....
To the Hawaii House Committees on Environment and Agriculture opposing establishment of advisory boards regarding genetically modified organisms
April 7, 2004
Letter to California Secretary of Agriculture: in support of Ventria Bioscience's application to grow a PMP rice variety outside of the state's major rice growing regio
BIO Statement on HCR 270/HR 180
April 7, 2004
To the Hawaii House Committees on Environment and Agriculture opposing establishment of advisory boards regarding genetically modified organisms (Apr. 7, 2004).
BIO, BayBIO, and BIOCOM
April 5, 2004
Letter to California Secretary of Agriculture: in support of Ventria Bioscience's application to grow a PMP rice variety outside of the state's major rice growing region (Apr. 5, 2004).
Comments regarding FDA's Draft Guidance for Industry
April 5, 2004
Providing Regulatory Submissions in Electronic Format ñ Content of Labeling.
Letter from Sens. Specter and Santorum and members of the House PA delegation
March 25, 2004
BIO Testimony
March 19, 2004
Testimony on the Biotechnology Industry Organization Submitted to the New York State Senate Committee on Environmental Conservation On behalf of the Biotechnology Industry Organization (BIO) and its more than 1,000 life science member...
Response to Notice 227 Patents Amendment Bill, 2004
March 18, 2004
New York Biotech Association
March 10, 2004
MEMORANDUM IN OPPOSITION OF LEGISLATION S. 6537, Senator Carl Marcellino Prohibits the sale of transgenic aquatic animals On behalf of our clients, the New York Biotechnology Association (NYBA), we oppose this legislation. This bill would make...
BIO Testimony opposing Alaska Senate Bill 281
March 3, 2004
On behalf of the Biotechnology Industry Organization and its more than 1,000 member companies, please accept this testimony in opposition of mandatory, generalized labeling requirements for biotech foods like those proposed in Senate Bill 281....
BIO Letter opposing Alaska House Bill 433 and Senate Bill 281
February 27, 2004
The Biotechnology Industry Organization (BIO) opposes mandatory, generalized labeling requirements for biotech foods like those proposed in House Bill 433. "An Act relating to labeling and identification of genetically modified fish and fish...
BIO Letter opposing Alaska House Bill 433 and Senate Bill 281
February 27, 2004
HB 433 and SB 281 propose to require labeling of biotech fish and fish products (Feb. 27, 2004).
CEO 2004 Keynote Address
February 25, 2004
Introduction If the situation were reversed, if I were going to introduce Carl, I would say that he has led this organization so ably because he is himself a true entrepreneur. His legacy is all around you, in the form of this conference, its...